Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengyi Tu

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Cardiovascular Research|October 1, 2020
Transcriptome analysis of non human primate-induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer culture vs. 3D engineered heart tissueHuaxiao Yang, Ningyi Shao, Alexandra Holmström, et al.
International Journal of Toxicology|September 9, 2025
Validating and Using Cardiac NAMs for Toxicity Screening and Drug DevelopmentJennifer Beck Pierson, Anthony Bahinski, Brian Berridge, et al.
Cell|October 16, 2024
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic targetHao Zhang, Phung N Thai, Rabindra V Shivnaraine, et al.
Nature Biomedical Engineering|November 27, 2023
Tachycardia-induced metabolic rewiring as a driver of contractile dysfunctionChengyi Tu, Arianne Caudal, Yu Liu, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Cardiovascular Research|October 1, 2020
Transcriptome analysis of non human primate-induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer culture vs. 3D engineered heart tissueHuaxiao Yang, Ningyi Shao, Alexandra Holmström, et al.
International Journal of Toxicology|September 9, 2025
Validating and Using Cardiac NAMs for Toxicity Screening and Drug DevelopmentJennifer Beck Pierson, Anthony Bahinski, Brian Berridge, et al.
Cell|October 16, 2024
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic targetHao Zhang, Phung N Thai, Rabindra V Shivnaraine, et al.
Nature Biomedical Engineering|November 27, 2023
Tachycardia-induced metabolic rewiring as a driver of contractile dysfunctionChengyi Tu, Arianne Caudal, Yu Liu, et al.
Pageof 4